Riskpilot← Back to searchSign inGet full accessHUNEMO AS
ASActiveOrg 911729563Øvre Ullern terrasse 3C, 0380 OsloOther human health activities n.e.c. · NACE 8699Est. 20130 employees
Revenue 2024
NOK 1,3M
+8% vs 2023
EBITDA margin
84.7%
+3% vs 2023
Equity ratio
56.3%
Financial strength
Net profit 2024
NOK 942K
+11% vs 2023
| Revenue | NOK 1,3M | +8% |
| EBITDA | NOK 1,1M | +3% |
| Net profit | NOK 942K | +11% |
| Total assets | NOK 1,8M | +30% |
| Equity | NOK 1M | +76% |
| Employees | 0 | — |
Legal name
HUNEMO AS
Org number
911729563
Legal form
Aksjeselskap
NACE code
8699 · Other human health activities n.e.c.
Founded
21. mars 2013
Share capital
NOK 30 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Styrets leder alene.
Company purpose
Tjenester for å fremme biomedisinsk og farmasøytisk forskning, utvikling og kommersialisering, og andre tjenester som naturlig faller sammen med dette, herunder å yte konsulenttjenester for ledelse og opplæring. Eie aksjer og andeler i andre virksomheter.
Address
Øvre Ullern terrasse 3C, 0380 Oslo
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 379 | 312 | 257 | 49 | 67 | 59 | 104 | 79 | 92 | 354 | 1 204 | 1 300 |
| Staff expenses | −1 | −3 | −2 | −6 | −4 | −3 | −2 | −1 | −1 | −0 | −0 | −2 |
| EBITDA | 237 | 167 | 140 | −77 | −11 | −68 | −11 | 26 | 29 | 251 | 1 068 | 1 101 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 |
| EBIT | 237 | 167 | 140 | −77 | −11 | −68 | −11 | 26 | 29 | 251 | 1 068 | 1 101 |
| Net financials | 0 | −2 | −27 | −24 | 5 | 3 | 620 | 0 | −0 | −0 | 13 | 88 |
| Profit before tax | 237 | 165 | 113 | −100 | −6 | −64 | 609 | 26 | 29 | 251 | 1 081 | 1 189 |
| Tax | 65 | 47 | 39 | −0 | −0 | −0 | −0 | −0 | −0 | 34 | 236 | 247 |
| Net profit | 173 | 117 | 74 | −100 | −6 | −64 | 609 | 26 | 29 | 217 | 846 | 942 |
| Item | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 357 | 329 | 285 | 109 | 113 | 77 | 640 | 368 | 102 | 405 | 1 398 | 1 811 |
| Equity | 97 | 114 | 188 | 87 | 82 | 18 | 326 | 52 | 80 | 33 | 578 | 1 020 |
| Long-term debt | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 259 | 215 | 97 | 21 | 31 | 60 | 314 | 316 | 22 | 372 | 820 | 791 |
| Total debt | 261 | 215 | 98 | 21 | 31 | 60 | 314 | 316 | 22 | 372 | 820 | 791 |
EBITDA margin
84.7%
This company
15.8%
Market median
+436% vs market
20132024
Equity ratio
56.3%
This company
38.2%
Market median
+47% vs market
20132024
Return on equity
92.3%
This company
18.4%
Market median
+402% vs market
20132024
Net profit margin
72.4%
This company
8.1%
Market median
+794% vs market
20132024
Asset turnover
0.72×
This company
1.12×
Market median
-36% vs market
20132024
Debt / equity
0.78×
This company
0.62×
Market median
+26% vs market
20132024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Brønnøysundsregistrene · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Brønnøysundsregistrene · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via Brønnøysundsregistrene · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via Brønnøysundsregistrene · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via Brønnøysundsregistrene · Period 2015-01-01 – 2015-12-31
- Annual report 2014Filed via Brønnøysundsregistrene · Period 2014-01-01 – 2014-12-31
- Annual report 2013Filed via Brønnøysundsregistrene · Period 2013-02-28 – 2013-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
KF Deputy Member | Deputy Member | 2013 | — | — |
OF Chief Executive Officer | Chief Executive Officer | 2013 | — | — |
SF Deputy Member | Deputy Member | 2013 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2013 | — | — |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
HUNEMO AS 
AURA BIOPHARM ASBoard members of HUNEMO AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Kristian Flaten | Deputy Member | 0 companies |
| Olav Flaten | Chief Executive Officer | 0 companies |
| Sverre Flaten | Deputy Member | 0 companies |
| Gro Bente Flaten | Board of Directors | 0 companies |